Annual Immunisation Coverage Report 2017

Authors

  • Brynley Hull National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children’s Hospital at Westmead and University of Sydney, Locked Bag 4001, Westmead, NSW 2145
  • Alexandra Hendry National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children’s Hospital at Westmead and University of Sydney, Locked Bag 4001, Westmead, NSW 2145
  • Aditi Dey National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children’s Hospital at Westmead and University of Sydney, Locked Bag 4001, Westmead, NSW 2145
  • Julia Brotherton National HPV Vaccination Program Register, Victorian Cytology Service, PO Box 310, East Melbourne, Vic 8002 1st
  • Kristine Macartney National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children’s Hospital at Westmead and University of Sydney, Locked Bag 4001, Westmead, NSW 2145
  • Frank Beard National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children’s Hospital at Westmead and University of Sydney, Locked Bag 4001, Westmead, NSW 2145

DOI:

https://doi.org/10.33321/cdi.2019.43.47

Keywords:

immunisation coverage, immunisation delay, Indigenous immunisation coverage, influenza vaccination, adolescent immunisation coverage, human papillomavirus vaccine coverage

Abstract

This eleventh national annual immunisation coverage report focuses on data for the calendar year 2017 derived from the Australian Immunisation Register (AIR) and the National Human Papillomavirus (HPV) Vaccination Program Register. This is the first report to include data on HPV vaccine course completion in Aboriginal and Torres Strait Islander (Indigenous) adolescents. ‘Fully immunised’ vaccination coverage in 2017 increased at the 12-month assessment age reaching 93.8% in December 2017, and at the 60-month assessment age reaching 94.5%. ‘Fully immunised’ coverage at the 24-month assessment age decreased slightly to 89.8% in December 2017, following amendment in December 2016 to require the fourth DTPa vaccine dose at 18 months. ‘Fully immunised’ coverage at 12 and 60 months of age in Indigenous children reached the highest ever recorded levels of 93.2% and 96.9% in December 2017. Catch-up vaccination activity for the second dose of measles-mumps-rubella-containing vaccine was considerably higher in 2017 for Indigenous compared to non-Indigenous adolescents aged 10–19 years (20.3% vs. 6.4%, respectively, of those who had not previously received that dose). In 2017, 80.2% of females and 75.9% of males aged 15 years had received a full course of three doses of human papillomavirus (HPV) vaccine. Of those who received dose one, 79% and 77% respectively of Indigenous girls and boys aged 15 years in 2017 completed three doses, compared to 91% and 90% of non-Indigenous girls and boys, respectively. A separate future report is planned to present adult AIR data and to assess completeness of reporting.

Downloads

Download data is not yet available.

References

Hull B, Deeks S, Menzies R, McIntyre P. Immunisation coverage annual report, 2007. Commun Dis Intell Q Rep. 2009;33(2):170–87.

Hull B, Dey A, Mahajan D, Menzies R, McIntyre PB. Immunisation coverage annual report, 2009. Commun Dis Intell Q Rep. 2011;35(2):132–48.

Hull B, Dey A, Menzies R, McIntyre P. Annual immunisation coverage report, 2010. Commun Dis Intell Q Rep. 2013;37(1):E21–39.

Hull BP, Dey A, Beard FH, Menzies RI, Brotherton JM, McIntyre PB. Immunisation coverage annual report, 2013. Commun Dis Intell Q Rep. 2016;40(1):E146–69.

Hull BP, Dey A, Menzies RI, Brotherton JM, McIntyre PB. Immunisation coverage annual report, 2011. Commun Dis Intell Q Rep. 2013;37(4):E291–312.

Hull BP, Dey A, Menzies RI, Brotherton JM, McIntyre PB. Immunisation coverage, 2012. Commun Dis Intell Q Rep. 2014;38(3):E208–31.

Hull BP, Hendry AJ, Dey A, Beard FH, Brotherton JM, McIntyre PB. Immunisation coverage annual report, 2014. Commun Dis Intell Q Rep. 2017;41(1):E68–90.

Hull BP, Mahajan D, Dey A, Menzies RI, McIntyre PB. Immunisation coverage annual report, 2008. Commun Dis Intell Q Rep. 2010;34(3):241–58.

Hull B, Hendry A, Dey A, Beard F, Brotherton J, McIntyre P.I Immunisation coverage annual report, 2015. Commun Dis Intell (2018). 2019;43. https://doi.org/10.33321/cdi.2019.43.11.

Hull B, Hendry A, Dey A, Beard F, Brotherton J, McIntyre P.I Annual immunisation coverage report, 2016. Commun Dis Intell (2018). 2019;43:in press. Available from: http://www.ncirs.edu.au/surveillance/immunisation-coverage/ (Accessed 19/07/2018).

Australian Institute of Health and Welfare. Immunisation rates for children in 2012–13. Australian Government, Australian Institute of Health and Welfare; 2014. Available from: https://www.aihw.gov.au/reports/immunisation/immunisation-rates-for-children-in-2012-13/contents/summary.

Australian Institute of Health and Welfare. Immunisation rates for children in 2014–15. Australian Government, Australian Institute of Health and Welfare; 2016. Available from: https://www.aihw.gov.au/reports/immunisation/immunisation-rates-for-children-in-2014-15/contents/summary

Australian Institute of Health and Welfare. Immunisation rates for children in 2015–16. Australian Government, Australian Institute of Health and Welfare; 2017. Available from: https://www.aihw.gov.au/reports/immunisation/immunisation-rates-for-children-in-2015-16/contents/summary

Hull BP, McIntyre PB, Heath TC, Sayer GP. Measuring immunisation coverage in Australia: a review of the Australian Childhood Immunisation Register. Aust Fam Physician. 1999;28(1):55–60.

Department of Health. Immunise Australia Program: Expansion of Registers. Australian Government, Department of Health, Canberra; 2016. [Accessed 21 October 2016.] Available from: http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/expansion-registers

National Centre For Immunisation Research and Surveillance. History of vaccination in Australia. National Centre for Immunisation Research and Surveillance, Sydney; 2019. Available from: http://www.ncirs.org.au/health-professionals/history-immunisation-australia

Department of Human Services. Australian Immunisation Register (AIR) – Immunisation medical exemption form (IM011). Australian Government, Department of Human Services, Canberra; 2016. [Accessed 24 October 2016.] Available from: https://www.humanservices.gov.au/organisations/health-professionals/forms/im011

Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook. Australian Government, Department of Health, Canberra; 2018. Available from: https://immunisationhandbook.health.gov.au

Department of Health. No Jab, No Pay – New Immunisation Requirements for Family Assistance Payments: Fact sheet for vaccination providers. Australian Government, Department of Health, Canberra; 2016. [Accessed 23 November 2017.] Available from: http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/67D8681A67167949CA257E2E000EE07D/$File/No-Jab-No-Pay-FSheet.pdf

Department of Health. National Immunisation Program Schedule. Australian Government, Department of Heath, Canberra; 2016. [Accessed 20 February 2018.] Available from: https://beta.health.gov.au/topics/immunisation/immunisation-throughout-life/national-immunisation-program-schedule

Department of Health. Clinical update: ATAGI advice on Rotarix® to replace RotaTeq®. Australian Government, Department of Health, Canberra; 2017. [Accessed 27 August 2018.] Available from: https://beta.health.gov.au/news-and-events/news/clinical-update-atagi-advice-on-rotarixr-to-replace-rotateqr

O’Brien ED, Sam GA, Mead C. Methodology for measuring Australia’s childhood immunisation coverage. Commun Dis Intell. 1998;22(3):36–7.

Hull BP, McIntyre PB. Immunisation coverage reporting through the Australian Childhood Immunisation Register – an evaluation of the third-dose assumption. Aust N Z J Public Health. 2000;24(1):17–21.

Hull BP, Lawrence GL, MacIntyre CR, McIntyre PB. Estimating immunisation coverage: is the ‘third dose assumption’ still valid? Commun Dis Intell Q Rep. 2003;27(3):357–61.

Hugo Centre for Migration and Population Research. Acessibility/Remoteness Index of Australia – ARIA++(2011). University of Adelaide, Hugo Centre for Migration and Population Research, Adelaide; 2011. [Accessed 17 November 2017.] Available from: https://www.adelaide.edu.au/hugo-centre/services/aria

Australian Bureau of Statistics. Australian Statistical Geography Standard (ASGS). Australian Government, Australian Bureau of Statistics, Canberra; 2011. [Accessed 17 November 2014.] Available from: http://www.abs.gov.au/websitedbs/d3310114.nsf/home/australian+statistical+geography+standard+%28asgs%29

MapInfo. MapInfo Pro version 15.0. Pitney Bowes Software, Stamford, Connecticut, USA; 2015.

Australian Bureau of Statistics. Australian Statistical Geography Standard (ASGS): Correspondences, July 2011 (Cat. no. 1270.0.55.006). Australian Government, Australian Bureau of Statistics, Canberra; 2012. [Accessed 17 November 2014.] Available from: http://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/1270.0.55.006Main+Features1July%202011?OpenDocument

Barbaro B, Brotherton JM. Measuring HPV vaccination coverage in Australia: comparing two alternative population-based denominators. Aust N Z J Public Health. 2015;39(4):326–30.

Australian Bureau of Statistics. 3101.0 – Australian Demographic Statistics, Jun 2017. Australian Government, Australian Bureau of Statistics, Canberra; 2017. [Accessed 12 September 2018.] Available from: http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/3101.0Jun%202017?OpenDocument (Accessed 12/09/2018).

Buttery JP, Lambert SB, Grimwood K, Nissen MD, Field EJ, Macartney KK, et al. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia’s National Childhood vaccine schedule. Pediatr Infect Dis J. 2011;30(1 Suppl):S25–9.

Dey A, Wang H, Menzies R, Macartney K. Changes in hospitalisations for acute gastroenteritis in Australia after the national rotavirus vaccination program. Med J Aust. 2012;197(8):453–7.

Dalton L, Meder K, Beard F, Dey A, Hull B, McIntyre P, et al. Australian Immunisation Register Data Transfer Study - Stage 2 Final Report. 2018. Available from: http://www.ncirs.org.au/sites/default/files/2018-12/2018%20AIR%20data%20tranfer%20report_FINAL_0.pdf

National Centre For Immunisation Research and Surveillance. Evaluation of the influenza immunisation program for Aboriginal and Torres Strait Islander children aged 6 months to <5 years. National Centre for Immunisation Research and Surveillance, Sydney; 2018. [Accessed 29 August 2018.] Available from: http://www.ncirs.edu.au/assets/surveillance/evaluation/Evaluation-of-Indigenous-Flu-final.pdf

Thompson C, Dey A, Fearnley E, Polkinghorne B, Beard F. Impact of the national targeted Hepatitis A immunisation program in Australia: 2000–2014. Vaccine. 2017;35(1):170–6.

Hull BP, McIntyre PB. What do we know about 7vPCV coverage in Aboriginal and Torres Strait Islander children? Commun Dis Intell Q Rep. 2004;28(2):238–43.

Menzies R, Turnour C, Chiu C, McIntyre P. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006. Commun Dis Intell Q Rep. 2008;32 (Suppl):S2–67.

Naidu L, Chiu C, Habig A, Lowbridge C, Jayasinghe S, Wang H, et al. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006–2010. Commun Dis Intell Q Rep. 2013;37(Suppl):S1–95.

Beard FH, Wood N. To sign or not to sign. Dealing with requests for vaccination exemption. Medicine Today. 2017;18(4):63–65. [Accessed 13 December 2017.] Available from: https://medicinetoday.com.au/2017/april/regular-series/sign-or-not-sign-dealing-requests-vaccination-exemption.

Brotherton J, Gertig D, Chappell G, Rowlands L, Saville M. Catching up with the catch-up: HPV vaccination coverage data for Australian women aged 18–26 years from the National HPV Vaccination Program Register. Commun Dis Intell Q Rep. 2011;35(2):197–201.

Brotherton JM, Murray SL, Hall MA, Andrewartha LK, Banks CA, Meijer D, et al. Human papillomavirus vaccine coverage among female Australian adolescents: success of the school-based approach. Med J Aust. 2013;199(9):614–7.

Machalek DA, Garland SM, Brotherton JML, Bateson D, McNamee K, Stewart M, et al. Very low prevalence of vaccine human papillomavirus types among 18- to 35-year old Australian women 9 years following implementation of vaccination. J Infect Dis. 2018;217(10):1590–600.

Garland SM, Cornall AM, Brotherton JML, Wark JD, Malloy MJ, Tabrizi SN, et al. Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program. Vaccine 2018;36(23):3221–30.

Australian Institute of Health and Welfare. Cervical screening in Australia 2018. Australian Government, Australian Institute of Health and Welfare, Canberra; 2018. [Accessed 31 August 2018.] Available from: https://www.aihw.gov.au/reports/cancer-screening/cervical-screening-in-australia-2018/contents/table-of-contents

World Health Organization. WHO Director-General calls for all countries to take action to help end the suffering caused by cervical cancer. WHO, Geneva, Switzerland; 2018. [Accessed 31 August 2018.] Available from: http://www.who.int/reproductivehealth/call-to-action-elimination-cervical-cancer/en/

Brisson M, Bénard É, Drolet M, Bogaards JA, Baussano I, Vänskä S, et al. Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models. Lancet Public Health. 2016;1(1):e8–17.

Downloads

Published

18/11/19

How to Cite

Hull, Brynley, Alexandra Hendry, Aditi Dey, Julia Brotherton, Kristine Macartney, and Frank Beard. 2019. “Annual Immunisation Coverage Report 2017”. Communicable Diseases Intelligence 43 (November). https://doi.org/10.33321/cdi.2019.43.47.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>